Related references
Note: Only part of the references are listed.Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength
W. Yao et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice
Amy Y. Sato et al.
BONE (2015)
Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial
Chi Chiu Mok et al.
BONE (2015)
Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone
Xiaolin Tu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells
Wanjing Zou et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2015)
Sirtuin1 (Sirt1) Promotes Cortical Bone Formation by Preventing β-Catenin Sequestration by FoxO Transcription Factors in Osteoblast Progenitors
Srividhya Iyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
High Bone Mass in Mice Lacking Cx37 Because of Defective Osteoclast Differentiation
Rafael Pacheco-Costa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats
Kathleen M. Hill Gallant et al.
PLOS ONE (2014)
Atypical Femoral Fractures, Bisphosphonates, and Mechanical Stress
Per Aspenberg et al.
CURRENT OSTEOPOROSIS REPORTS (2014)
Glucocorticoid-induced skeletal muscle atrophy
O. Schakman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization
Kuniaki Ota et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
FOXOs attenuate bone formation by suppressing Wnt signaling
Srividhya Iyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Prevalence of oral glucocorticoid usage in the United States: A general population perspective
Robert A. Overman et al.
ARTHRITIS CARE & RESEARCH (2013)
Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids
Amy H. Warriner et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading
Xiaolin Tu et al.
BONE (2012)
Management of Glucocorticoid-Induced Osteoporosis
R. Rizzoli et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Sclerostin Antibody Treatment Enhances Bone Strength but Does Not Prevent Growth Retardation in Young Mice Treated With Dexamethasone
M. Marenzana et al.
ARTHRITIS AND RHEUMATISM (2011)
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
L. I. Plotkin et al.
BONE (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts
Maria Almeida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling
Yumie Rhee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Glucocorticoid-Induced Bone Disease
Robert S. Weinstein
NEW ENGLAND JOURNAL OF MEDICINE (2011)
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
Stavros C. Manolagas
ENDOCRINE REVIEWS (2010)
Glucocorticoids Are Not Always Deleterious for Bone
Antoon H. J. M. van Lierop et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Antagonistic Interplay Between Mechanical Forces and Glucocorticoids in Bone: A Tale of Kinases
Teresita Bellido
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Ina Kramer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Prevention of Glucocorticoid-Induced Bone Loss in Mice by Inhibition of RANKL
Lorenz C. Hofbauer et al.
ARTHRITIS AND RHEUMATISM (2009)
Intravenous Bisphosphonate-Related Osteonecrosis of the Jaw: Bone Scintigraphy as an Early Indicator
Felice S. O'Ryan et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
Lilian I. Plotkin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs
M. R. Allen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival - Evidence for inside-out signaling leading to anoikis
Lillian I. Plotkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density
D. Jia et al.
ENDOCRINOLOGY (2006)
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
Matthew R. Allen et al.
BONE (2006)
Bone demineralization and vertebral fractures in endogenous cortisol excess:: Role of disease etiology and gonadal status
L Tauchmanová et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Glucocorticoid-induced osteoporosis: an update
Gherardo Mazziotti et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss
JI Aguirre et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis
T. P. van Staa
CALCIFIED TISSUE INTERNATIONAL (2006)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism
T Bellido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased risk of osteoporotic fractures in patients with Cushing's syndrome
P Vestergaard et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles
T Mashiba et al.
BONE (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
